ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1962

The Value Of the  2010 ACR/EULAR Rheumatoid Arthritis Classification Criteria For The Prognosis Of Early Arthritis: Evaluation Of Erosion Development With Ultrasonography

Nevsun Inanc1, Fatma Alibaz-Oner2, Meryem Can3, Pamir Atagündüz2 and Haner Direskeneli2, 1Department of Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, 2Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 3Department of Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: classification criteria and ultrasonography, Early Rheumatoid Arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The 2010  ACR/EULAR Rheumatoid Arthritis(RA) classification criteria was developed to diagnose the early arthritis patients who will progress destructive disease and to start  early treatment. We aimed to investigate the value of these classification criteria for the prognosis of early arthritis patients with the evaluation of the longitudinal ultrasonographic(US) examination for the development of erosions.

Methods:

The study included patients presenting with at least one swollen joints to “Early arthritis Clinic” between 2009 and 2012.  The patients having  symptom duration less than 24 months were recruited to the study. Clinical evaluation(tender/swollen joint counts, DAS28 and HAQ scores) and US examination of erosion at 2nd MCP, 5th MCP, 2nd PIP ulnar styloid and 5th MTP joints were performed prospectively at the lateral approach longitudinally and transversally for  the determination of the erosion at baseline and 12months.

Results:

A total of 71 patients (F/M:53/18) were recruited to the study.  The mean age was 38.2± 14.2, mean symptom duration was 6.4 (0-24) months.  At baseline assessment, 46.5% (n:33) of patients were classified as RA  according to 2010 ACR/EULAR criteria and others were diagnosed as undiffererentiated arthritis(UA) after excluding other possible diagnosis.

At baseline, higher percentage of patients whom was diagnosed as RA according to 2010 ACR/EULAR criteria (44 % vs 23%, p= 0.072) were found to have erosive changes with the US examination.  Furthermore, a tendency was observed for the progression of erosive disease, in terms of increased number of erosive joints, in patients diagnosed according to 2010 criteria vs patients diagnosed as UA (32% vs 10 %, p=0.072) at follow-up. Positive RF was also determined as a predictor of erosions by US ( 35% vs 11%, p=0.053). 

Conclusion:

Among patients with early arthritis fulfilling the 2010 ACR/EULAR RA criteria had erosive disease at diagnosis and increased frequency of erosions during the follow-up. Early evaluation of the joints by US can be used for the  early detection of erosive patients which may predict the prognosis of RA.


Disclosure:

N. Inanc,
None;

F. Alibaz-Oner,
None;

M. Can,
None;

P. Atagündüz,
None;

H. Direskeneli,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-value-of-the-2010-acreular-rheumatoid-arthritis-classification-criteria-for-the-prognosis-of-early-arthritis-evaluation-of-erosion-development-with-ultrasonography/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology